| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.47 | 0.003 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.095 | 0.005 |